‹ All Posts
Unite Technologies Financial

16th Dec · SEBI-Registered Analyst

NATCO Pharma Limited (1D )

NATCOPHARM
is currently in an uptrend but appears to be encountering selling pressure near the ₹950 mark. ₹950 is a crucial resistance zone. A decisive breakout above this level, preferably with good volume, is required to resume the strong rally. Moving Averages: Prices are above the MAs, and the MAs are sloping upwards, indicating that the bullish control is still intact despite the recent pause. Potential Move: If the stock clears the ₹950 resistance, it could target the ₹980–₹1,000 levels. Downside support is located around the ₹905–₹910 zone.

#WatchOutFor#TechnicalViews#StockInNews#TrendingSectors
NATCO PHARMA .png
505 likes·82 comments